FLUTICASONE / VILANTEROL INHALER (Relvar®)
Clinical Indication
Asthma
Comments
Reviewed by LLR Respiratory Prescribing Group.
Date of classification
February 2017
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.